PT  - JOURNAL ARTICLE
AU  - Fraza, Charlotte
AU  - Sønderby, Ida E.
AU  - Boen, Rune
AU  - Beckmann, Christian F.
AU  - Marquand, Andre F.
TI  - Unraveling the Link between CNVs, General Cognition, and Individual Neuroimaging Deviation Scores from a Reference Cohort
AID  - 10.1101/2023.11.29.23298954
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.11.29.23298954
4099  - http://medrxiv.org/content/early/2023/11/30/2023.11.29.23298954.short
4100  - http://medrxiv.org/content/early/2023/11/30/2023.11.29.23298954.full
AB  - Background Copy number variations (CNVs) are genetic variants that can have substantial influence on neurodevelopment, neuropsychiatric traits and morphometric brain changes, yet their impact at the individual level remains unknown. Common case-control approaches for analyzing CNVs often overlook individual variation between carriers and exclude rarer variants, due to their limited sample size. This study aims to map individualized brain deviation scores in individuals with pathogenic CNVs.Methods We used normative modeling to map neuroimaging features from several large neuroimaging datasets and applied these models to understand the neurobiological profile of CNV carriers in UK Biobank. We highlighted the 1q21.1 distal deletion and duplication, as an example of our normative modeling-CNV approach. Next, we counted the number of extreme deviations for each participant from the mean and centiles of variation from population reference norms, giving us a combined risk score per participant per imaging modality.Results We show a high degree of heterogeneity between pathogenic CNV carriers in their implicated brain regions. For example, the cerebellum, brainstem and the pallidum show large negative deviations for certain 1q21.1 duplication carriers. For certain 1q21.1 deletion CNV carriers the caudate and accumbens show notable positive deviations. Finally, we show that negative deviations from these models are correlated to cognitive function.Conclusions This study marks a starting point in comprehending the impact of pathogenic CNVs on brain phenotypes, underscoring the intricacies of these genetic variations at the individual level and provides a means to studying the effects of rare CNVs in carrier individuals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by grants from the European Research Council (ERC, grant MENTALPRECISION 10100118) and the Dutch Organisation for Scientific Research (VIDI grant 016.156.415). This research has been conducted using the UK Biobank resource under application number 23668. Rune Boen and Ida Sonderby are supported by the Research Council of Norway (223273) and South-Eastern Norway Regional Health Authority (2020060). In addition, Ida Sonderby is supported by the European Union Horizon2020 Research and Innovation Programme (CoMorMent project; Grant 847776) and Kristian Gerhard Jebsen Stiftelsen (SKGJ-MED-021).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All the data employed in this study were sourced from publicly accessible repositories: Cam-CAN (https://www.cam-can.org/), HCP (https://www.humanconnectome.org/), Oasis (https://www.oasis-brains.org/), PNC (https://www.med.upenn.edu/bbl/philadelphianeurodevelopmentalcohort.html), and UK Biobank (https://www.ukbiobank.ac.uk/).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data utilized comes exclusively from open-source neuroimaging databases, which are available at Cam-CAN (https://www.cam-can.org/), HCP (https://www.humanconnectome.org/), Oasis (https://www.oasis-brains.org/), PNC (https://www.med.upenn.edu/bbl/philadelphianeurodevelopmentalcohort.html), and UK Biobank (https://www.ukbiobank.ac.uk/).